Donna Felsenstein: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author")
m (Undo revision 110300 by Notjusttired (talk))
Line 1: Line 1:
{{NeedsImage}}
{{NeedsImage}}
'''Donna Felsenstein''', M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US<ref name=":0" /> and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH)'''.'''<ref name=":1">{{Cite web|url=https://www.omf.ngo/collaborative-research-center-harvard/|title=ME/CFS Collaborative Research Center at Harvard, funded by OMF|website=Open Medicine Foundation|language=en-US|access-date=2019-09-03}}</ref> She serves as a member of the scientific team with the Open Medicine Foundation.<ref name=":1" /> Since 1979, she has been diagnosing and caring for patients with ME/CFS.<ref name=":1" /> Her listed specialities include [[Lyme disease]], Infectious diseases, and [[Herpes simplex virus]].<ref name=":0">{{Cite web|url=https://www.massgeneral.org/doctors/doctor.aspx?id=16629|title=Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA|website=www.massgeneral.org|access-date=2019-09-03}}</ref>
'''Donna Felsenstein''', M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US<ref name=":0" /> and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH)'''.'''<ref name=":1">{{Cite web|url=https://www.omf.ngo/collaborative-research-center-harvard/|title=ME/CFS Collaborative Research Center at Harvard, funded by OMF|website=Open Medicine Foundation|language=en-US|access-date=2019-09-03}}</ref> She serves as a member of the scientific team with the Open Medicine Foundation.<ref name=":1" /> Since 1979, she has been diagnosing and caring for patients with ME/CFS.<ref name=":1" /> Her listed specialities include [[Lyme disease]], Infectious diseases, and [[Herpes simplex virus]].<ref name=":0">{{Cite web|url=https://www.massgeneral.org/doctors/doctor.aspx?id=16629|title=Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA|website=www.massgeneral.org|access-date=2019-09-03}}</ref>
==Notable studies==
==Notable studies==
Line 26: Line 25:
==References==
==References==
<references>
<references>
<ref name="KlimasNG, 2015">{{Citation |last1  = Klimas |first            1  |authorlink1 = Nancy Klimas |last2  = Ironson |first           |authorlink2 = |last3  = Carter |first            3  |authorlink3 = |last4  = Balbin |first            4  |authorlink4 = Elizabeth Balbin |last5  = Bateman |first           |authorlink5 = Lucinda Bateman |last6  = Felsenstein |first      6  |authorlink6 = Donna Felsenstein |last7  = Levine |first            7  |authorlink7 = Susan Levine |last8  = Peterson |first          8  |authorlink8 = Daniel Peterson |last9  = Chiu |first              9  |authorlink9 = |last10  = Allen |first            10  |authorlink10 = |last11  = Cunningham |first        11  |authorlink11 = |last12  = Gottschalk |first       12  |authorlink12 = Gunnar Gottschalk |last13  = Fletcher |first          13  |authorlink13 = Mary Ann Fletcher |last14  = Hornig |first            14  |authorlink14 = Mady Hornig |last15  = Canning |first          15  |authorlink15 = |last16  = Komaroff |first          16  |authorlink16 = Anthony Komaroff
<ref name="KlimasNG, 2015">{{Citation
| last1  = Klimas           | first1 = N.G.        | authorlink1 = Nancy Klimas
| last2  = Ironson           | first2 = G.           | authorlink2 =  
| last3  = Carter           | first3 = A.          | authorlink3 =  
| last4  = Balbin           | first4 = E.          | authorlink4 = Elizabeth Balbin
| last5  = Bateman           | first5 = L.           | authorlink5 = Lucinda Bateman
| last6  = Felsenstein       | first6 = D.          | authorlink6 = Donna Felsenstein
| last7  = Levine           | first7 = S.          | authorlink7 = Susan Levine
| last8  = Peterson         | first8 = D.          | authorlink8 = Daniel Peterson
| last9  = Chiu             | first9 = K.          | authorlink9 =
| last10  = Allen             | first10 = A.          | authorlink10 =
| last11  = Cunningham       | first11 = K.          | authorlink11 =
| last12  = Gottschalk       | first12 = C.G.       | authorlink12 = Gunnar Gottschalk
| last13  = Fletcher         | first13 = M          | authorlink13 = Mary Ann Fletcher
| last14  = Hornig           | first14 = M.          | authorlink14 = Mady Hornig
| last15  = Canning           | first15 = C.          | authorlink15 =
| last16  = Komaroff         | first16 = A.L.        | authorlink16 = Anthony Komaroff
| title  = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome
| title  = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome
| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 3 | issue =  2| page = 75-96
| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 3 | issue =  2| page = 75-96

Revision as of 16:41, May 11, 2022

Donna Felsenstein, M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US[1] and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH).[2] She serves as a member of the scientific team with the Open Medicine Foundation.[2] Since 1979, she has been diagnosing and caring for patients with ME/CFS.[2] Her listed specialities include Lyme disease, Infectious diseases, and Herpes simplex virus.[1]

Notable studies[edit | edit source]

  • 2010, Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions[3] - (Full text)
  • 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[4] - (Full text)
  • 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[5] - (Abstract)

Clinic location[edit | edit source]

55 Fruit St, Boston, MA 02114

Phone: (617) 726-3812

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 "Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA". www.massgeneral.org. Retrieved September 3, 2019.
  2. 2.0 2.1 2.2 "ME/CFS Collaborative Research Center at Harvard, funded by OMF". Open Medicine Foundation. Retrieved September 3, 2019.
  3. Henrich, Timothy J.; Li, Jonathan Z.; Felsenstein, Donna; Kotton, Camille N.; Plenge, Robert M.; Pereyra, Florencia; Marty, Francisco M.; Lin, Nina H.; Grazioso, Paul (November 15, 2010). "Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions". The Journal of Infectious Diseases. 202 (10): 1478–1481. doi:10.1086/657168. ISSN 0022-1899. PMC 2957553. PMID 20936980.
  4. Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
  5. Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652